Arun Jeyabalan: Influence Statistics

Arun Jeyabalan

Arun Jeyabalan

Department of Obstetrics, Gynecology and Reproductive Science, UPMC Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA. | University of ...

Arun Jeyabalan: Expert Impact

Concepts for which Arun Jeyabalan has direct influence: Postpartum preeclampsia , Preeclampsia women , Hypertensive disorders , Hypertensive disorder , Maternal circulation , Women preeclampsia , Pregnancy preeclampsia .

Arun Jeyabalan: KOL impact

Concepts related to the work of other authors for which for which Arun Jeyabalan has influence: Pregnant women , Gestational diabetes , Hypertensive disorders , Angiogenic factors , Growth factor , Hellp syndrome , Severe preeclampsia .

KOL Resume for Arun Jeyabalan

Year
2022

Department of Obstetrics, Gynecology and Reproductive Science, UPMC Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Magee-Womens Hospital, University of Pittsburgh, Pittsburgh, PA

2021

Department of Obstetrics, Gynecology, & Reproductive Sciences, University of Pittsburgh, Pittsburgh, USA.

Global Pregnancy Collaboration, Pittsburgh, PA, USA

2020

Department of Obstetrics, Gynecology, & Reproductive Sciences, School of Medicine; University of Pittsburgh, Pennsylvania, USA

Global Pregnancy Collaboration

2019

Department of Ob/Gyn and Reproductive Sciences, Magee-Women's Research Institute and Clinical and Translational Sciences Research Institute, University of Pittsburgh, PA (J.M.C., A.J., J.M.R.).

Division of Maternal-Fetal Medicine, Magee-Women's Research Institute, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA.

Magee-Womens Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA

2018

Department of Obstetrics, Gynecology and Reproductive Sciences, Univeristy of Pittsburgh School of Medicine, United States; Magee-Womens Research Institute, University of Pittsburgh, United States; Clinical and Translational Science Institute, University of Pittsburgh School of Medicine, United States.

Magee-Womens Research Institute, University of Pittsburgh, 204 Craft Avenue, Pittsburgh, PA, USA

2016

Department of Obstetrics and Gynecology and Reproductive Sciences, University of Pittsburgh, Pittsburgh, PA

2015

Professor and Vice Chair for Research, Department of Obstetrics and Gynecology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA

2014

From the Department of Animal Reproduction, Universidad Nacional de Rio Cuarto, Rio Cuarto, Cordoba, Argentina (M.B.R.); Department of Obstetrics and Laboratory of Neuroimmunology and Developmental Origins of Disease, University Medical Center Utrecht, Utrecht, The Netherlands (E.D.P.U.); Department of Ob/Gyn, Magee Womens Hospital, Pittsburgh, PA (A.J., W.A.H.); and D.H. Barron Reproductive and Perinatal Biology Research Program, Departments of Physiology and Functional Genomics and of Ob/Gyn, University of Florida, Gainesville (E.D.P.U., K.P.C.).

Magee-Womens Research Institute and Foundation, University of Pittsburgh, Pittsburgh, PA, USA

2013

University of Pittsburgh School of Medicine Department of Obstetrics, Gynecology and Reproductive Sciences Pittsburgh Pennsylvania USA

2012

Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

Magee‐Womens Research Institute

2010

School of Medicine, Department of Obstetrics and Gynecology, University of Pittsburgh, Pittsburgh, PA, USA

Magee-Womens Research Institute, University of Pittsburgh, Pittsburgh, Pennsylvania

2009

Magee-Womens Research Institute and the Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA

2008

School of Medicine, Department of Obstetrics and Gynecology, University of Pittsburgh, Pittsburgh, PA 15261, USA

2007

Departments of 1Obstetrics, Gynecology and Reproductive Sciences, and 2Epidemiology, Graduate School of Public Health and 4Cell Biology and Physiology, University of Pittsburgh School of Medicine and Magee Womens Research Institute Pittsburgh and 3Pediatrics, Allegheny General Hospital and Drexel University School of Medicine, Pittsburgh, Pennsylvania

2005

Department of Ob/Gyn and Reproductive Sciences, Pittsburgh, Pennsylvania 15213, USA

2004

School of Surgical and Reproductive Sciences, University of Newcastle upon Tyne, Royal Victoria Infirmary, Newcastle, United Kingdom; Medical Faculty of the Charité, Franz Volhard Clinic HELIOS Klinikum-Berlin and Max Delbrück Center for Molecular Medicine, Berlin, Germany; Departments of Ob/Gyn and Reproductive Sciences and Cell Biology and Physiology, University of Pittsburgh School of Medicine and Magee-Womens Research Institute, Pittsburgh, Pennsylvania; Departments of Medicine and Obstetrics and Gynecology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts; and The Samuel Lunenfeld Research Institute and Mount Sinai Hospital, Toronto, Ontario, Canada

Prominent publications by Arun Jeyabalan

KOL-Index: 20678 . BACKGROUND: Women with a history of hypertensive disorders of pregnancy are at an increased risk of hypertension and cardiovascular disease in later life. Lactation has been associated with a reduced risk of maternal hypertension, both in the postpartum period and later life. However, little is known about whether lactation is also cardioprotective in women with hypertensive disorders of ...
Known for Blood Pressure | Lactation Women | Gestational Hypertension | Hypertensive Disorders
KOL-Index: 13611 . BACKGROUND: Differences in circulating concentrations of antiangiogenic factors sFlt1 and soluble endoglin (sEng) and the pro-angiogenic growth factor PlGF are reported to precede the onset of preeclampsia weeks to months in low-risk pregnant women. The objective of this study was to investigate whether similar changes can be detected in pregnant women at high-risk to develop the ...
Known for Preeclampsia Women | Placental Growth | Risk Pregnancies | Tyrosine Kinase
KOL-Index: 11461 . BACKGROUND: Cigarette smoking during pregnancy is paradoxically associated with a reduced risk of developing preeclampsia. Both smoking and preeclampsia are associated with alterations in circulating angiogenic factors. The objective of this study was to investigate the relationship between cigarette smoking and the angiogenic factors soluble fms-like tyrosine kinase-1 (sFlt-1) and ...
Known for Angiogenic Factors | Cigarette Smoke Exposure | Pregnancy Preeclampsia | Smokers Nonsmokers
KOL-Index: 11272 . BACKGROUND: Preeclampsia is a pregnancy-specific disorder that remains a leading cause of maternal, fetal and neonatal morbidity and mortality, and is associated with risk for future cardiovascular disease. There are no reliable predictors, specific preventative measures or treatments other than delivery. A widely held view is that the antecedents of preeclampsia lie with impaired ...
Known for Gene Expression | Trimester Placentas | Women Preeclampsia | Microarray Analysis
KOL-Index: 11198 . Preeclampsia is a heterogeneous syndrome affecting 3% to 5% of all pregnancies. An imbalance of the antiangiogenic and proangiogenic factors, soluble receptor fms-like tyrosine kinase 1 and placental growth factor (PGF), is thought to contribute to the pathophysiology of preeclampsia. Maternal plasma PGF and soluble receptor fms-like tyrosine kinase 1 were quantified by specific ...
Known for Growth Factor | Preterm Preeclampsia | Preeclamptic Patients | 3 5
KOL-Index: 10387 . BACKGROUND: Preeclampsia is a hypertensive, multi-system pregnancy disorder whose pathophysiology remains unclear. Elevations in circulating soluble endoglin (sENG) and placental/blood ENG mRNA expression antedate the clinical onset of preeclampsia. This study investigated if endoglin (ENG) pathway genetic variation was also associated with the development of preeclampsia. METHODS: We used ...
Known for Endoglin Pathway | Transforming Growth Factor | Gene Association | Control Candidate
KOL-Index: 10202 . Impaired uterine invasion by extravillous trophoblast in early gestation is implicated in the genesis of preeclampsia, a potentially lethal malady of human pregnancy. However, reasons for extravillous trophoblast dysfunction remain unclear because of virtual inaccessibility of early placental and uterine tissues from women who develop preeclampsia, and the absence of animal models in which ...
Known for Early Pregnancy | Women Preeclampsia | Extravillous Trophoblast | Chorionic Villous Samples
KOL-Index: 9606 . Inadequate trophoblast invasion and spiral artery remodeling leading to poor placental perfusion are believed to underlie the pregnancy pathologies preeclampsia (PE) and intrauterine growth restriction (IUGR). The main objective of this study was to investigate hypoxia-inducible transcription factor-alpha (HIF-alpha) and downstream genes (VEGF receptor-1) Flt-1 and soluble fms-like ...
Known for Intrauterine Growth Restriction | Normotensive Pregnancies | Iugr Placentas | Alpha Subunit Infant
KOL-Index: 9509 . BACKGROUND: Though moderate- to vigorous-intensity physical activity is recommended, limited research exists on sedentary behavior (SED) during pregnancy. METHODS: The authors conducted a prospective cohort study to describe objectively measured patterns of SED and activity during each trimester of pregnancy. Women wore thigh- (activPAL3) and waist-mounted (ActiGraph GT3X) activity ...
Known for Physical Activity | Sedentary Behavior | Sed Pregnancy | Objectively Measured
KOL-Index: 8763 . BACKGROUND: Shorter gestation or smaller birth size are indicators of a suboptimal fetal environment and negatively impact short- and long-term offspring health. Understanding how modifiable maternal behaviours, such as moderate-to-vigorous intensity physical activity (MVPA) or sedentary behaviour (SED), improve fetal outcomes could inform strategies to improve health across the ...
Known for Physical Activity | Sed Mvpa | Gestational Age | Pregnancy Birth
KOL-Index: 8691 . OBJECTIVE: We hypothesized that body composition would be similar among neonates of women with gestational diabetes (GDM) treated with glyburide or insulin. STUDY DESIGN: Women with GDM requiring medical therapy were randomized to insulin or glyburide. The primary outcome was percent neonatal fat mass measured by total body electrical conductivity. Secondary outcomes included ...
Known for Neonatal Adiposity | Gestational Diabetes | Glyburide Insulin | Women Gdm
KOL-Index: 8511 . The cardinal manifestations of the pregnancy-specific disorder preeclampsia, new-onset hypertension, and proteinuria that resolve with placental delivery have been linked to an extracellular protein made by the placenta, soluble fms-like tyrosine kinase 1 (sFlt1), that injures the maternal vasculature. However, the mechanisms by which sFlt1, which is heavily matrix bound, gain access to ...
Known for Maternal Circulation | Syncytial Aggregates | Tyrosine Kinase | Soluble Fms
KOL-Index: 8372 . OBJECTIVES: Hypertension and obesity are common cardiometabolic risk factors in reproductive age women. The association of hypertensive disorders of pregnancy with later-life cardiovascular disease is well-established, however, it is unknown how obesity and hypertensive disorders of pregnancy converge to accelerate development of hypertension in the postpartum period. The aim of this study ...
Known for Hypertensive Disorders | Normotensive Pregnancy | Postpartum Period | Risk Hypertension
KOL-Index: 7655 . OBJECTIVE: Vitamin D deficiency has been linked to the pathogenesis of preeclampsia. Given the demonstrated antiinflammatory function of vitamin D in multiple organ systems including trophoblast cells and placenta, we hypothesized that vitamin D deficiency contributes to the development of preeclampsia through increased inflammation, as indicated by elevated interleukin (IL)-6 ...
Known for Vitamin Deficiency | Pathogenesis Preeclampsia | Association Il6 | Preeclamptic Women
KOL-Index: 7354 . OBJECTIVE: We sought to determine whether haptoglobin (Hp) phenotype is related to preeclampsia risk, or to plasma concentrations of soluble endoglin (sEng), soluble fms-like tyrosine kinase 1 (sFlt-1), and placental growth factor (PlGF). STUDY DESIGN: Hp phenotype was retrospectively determined in primiparous women with uncomplicated pregnancies (n = 309), gestational hypertension (n = ...
Known for Preeclampsia Risk | Haptoglobin Phenotype | Angiogenic Factors | Sflt1 Plgf

Key People For Postpartum Preeclampsia

Top KOLs in the world
#1
Baha M Sibaı̈
severe preeclampsia gestational age cesarean delivery
#2
Ray Oliver Bahado‐Singh
nuchal thickness maternal age syndrome detection
#3
Awoniyi O Awonuga
adhesion development stem cells elective cryopreservation
#4
Anthony N Imudia
united states endometrial biopsy benign indications
#5
Zain A Al‐Safi
obese women uterine artery embolization delayed postpartum preeclampsia
#6
Deslyn T G Hobson
delayed postpartum preeclampsia nonhormonal alternative candy cane

Department of Obstetrics, Gynecology and Reproductive Science, UPMC Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA. | University of Pittsburgh School of Medicine | Magee-Womens Hospital, University of Pittsburgh, P